Factors associated with prolonged time to treatment failure with fulvestrant 500 mg in patients with postmenopausal estrogen receptor-positive advanced/metastatic breast cancer (JBCRG-C06; Safari): A subgroup analysis

DOI Open Access

Search this article

Journal

Details 詳細情報について

Report a problem

Back to top